2000 ceocfointerviews.com - All rights reserved.
Contact Info: e-mail - info@ceocfointerviews.com.  
PO Box 245, Swiftwater, PA 18370; Phone: 570 - 839 - 0CEO.
   

Cover Story

CEOCFO
Interview
Index &
Quotes

CEOCFO
Current Issue

Monthly
Analyst
Industry
Review

Analyst
Interviews
and Reports

Corporate
Financials

Newsflash!

Stock Pick 
of the Month -
Analyst
Quotes

  
Archived
CEOCFO
Interviews

 
Officers

No more paper

making clinical trials paperless

 

Biotechnology & Drugs, Sector: Healthcare, NASDAQ: DATA

Data Trak International

20600 Chagrin Blvd.,Cleveland, OH  44122

Dr. Jeffrey A. Green, President and Chief Executive Officer

Interviewer conducted by: Diane Reynolds, Co-Publisher

CEOCFOinterviews.com, December 2000

Brief History and Background

My name is Dr. Jeffrey Green and I have been in the clinical trials industry for the past twenty years. I am a pharmacist and graduated from Purdue. I received a Doctor of Pharmacy Degree in 1982 from the University of Texas. I then went into performing clinical trials for the pharmaceutical industry as a research investigator at Case Western Reserve University. I left the university to go on the entrepreneurial and corporate side of clinical trials.

CEOCFOinterviews: Data Trak International, it’s not really a drug company or biotech company, explain this to my readers, it’s a little unique.

Dr. Green: It is and we are actually quite proud of that. DATATRAK International is in a new market niche and a developing market niche called “application service providers”. We provide hosting and software applications to run clinical research data for the pharmaceutical industry over the Internet. Why that’s important is, and this may shock some of your readers, but the way that the data is collected for clinical trials in the pharmaceutical industry and in national institute of health or anyone who does clinical research is data is collected by people flying around in airplanes to pick up paper. We believe this process should run electronically over the Internet.

CEOCFOinterviews: I understand this will reduce the clinical trial duration by 30%.

To receive a complete copy of this interview call: 570-839-0236

ceocfointerviews.com does not purchase or make
recommendation on stocks based on the interviews published.